Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure.
Saved in:
| Title: | Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure. |
|---|---|
| Authors: | Jayanti RP; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea., Cho YS; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea., Soedarsono S; Sub-Pumonology Department of Internal Medicine, Faculty of Medicine, Hang Tuah University, Surabaya, Indonesia.; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.; Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.; Dr. Soetomo General Hospital, Surabaya, Indonesia., Kim HJ; Division of Pulmonology, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Busan, Republic of Korea., Kang J; Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea., Kim J; Pulmonary Division, Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Republic of Korea., Oh JY; Division of Pulmonology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea., Kang BH; Division of Pulmonology, Department of Internal Medicine, Dong-A University Hospital, Busan, Republic of Korea., Ha JH; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Kim JW; Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Mertaniasih NM; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.; Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.; Departement of Clinical Microbiology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia., Kusmiati T; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.; Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.; Dr. Soetomo General Hospital, Surabaya, Indonesia., Permatasari A; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.; Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.; Dr. Soetomo General Hospital, Surabaya, Indonesia., Yuliwulandari R; Faculty of Medicine, University of Pembangunan Nasional Veteran Jawa Timur, Surabaya, Indonesia., Kim R; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea., Seong HJ; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea., Ghim JL; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea., Kim DH; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea., Shin JG; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea. |
| Corporate Authors: | cPMTb |
| Source: | PloS one [PLoS One] 2026 Jan 29; Vol. 21 (1), pp. e0340133. Date of Electronic Publication: 2026 Jan 29 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0340133 |
